Suppr超能文献

Corrigendum to "Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression" [Eur. J. Pharmacol. (2021) 890 173669].

作者信息

Hua Dan, Zhao Qian, Yu Yang, Yu Huan, Yu Lin, Zhou Xuexia, Wang Qian, Sun Cuiyun, Shi Cuijuan, Luo Wenjun, Jiang Zhendong, Wang Weiting, Wang Lingli, Zhang Dongli, Tang Shengan, Yu Shizhu

机构信息

Department of Neuropathology, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, 300052, China; Tianjin Key Laboratory of Injuries, Variations and Regeneration of the Nervous System, Tianjin, 300052, China; Key Laboratory of Post-trauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin, 300052, China.

Department of Sports Injury and Arthroscopy, Tianjin University Tianjin Hospital, Tianjin, 300221, China.

出版信息

Eur J Pharmacol. 2022 Apr 15;921:174897. doi: 10.1016/j.ejphar.2022.174897. Epub 2022 Mar 12.

DOI:10.1016/j.ejphar.2022.174897
PMID:35292175
Abstract
摘要

相似文献

1
Corrigendum to "Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression" [Eur. J. Pharmacol. (2021) 890 173669].
Eur J Pharmacol. 2022 Apr 15;921:174897. doi: 10.1016/j.ejphar.2022.174897. Epub 2022 Mar 12.
2
Eucalyptal A inhibits glioma by rectifying oncogenic splicing of MYO1B mRNA via suppressing SRSF1 expression.
Eur J Pharmacol. 2021 Jan 5;890:173669. doi: 10.1016/j.ejphar.2020.173669. Epub 2020 Oct 22.
3
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B.
J Clin Invest. 2019 Feb 1;129(2):676-693. doi: 10.1172/JCI120279. Epub 2019 Jan 14.
4
AMP-activated protein kinase regulates alternative pre-mRNA splicing by phosphorylation of SRSF1.
Biochem J. 2020 Jun 26;477(12):2237-2248. doi: 10.1042/BCJ20190894.
5
The RNA-binding protein SRSF1 is a key cell cycle regulator via stabilizing NEAT1 in glioma.
Int J Biochem Cell Biol. 2019 Aug;113:75-86. doi: 10.1016/j.biocel.2019.06.003. Epub 2019 Jun 11.
6
Protein kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer protein.
Genes Cancer. 2011 Aug;2(8):841-51. doi: 10.1177/1947601911430226.
7
Corrigendum to "α-Conidendrin inhibits the expression of intercellular adhesion molecule-1 induced by tumor necrosis factor-α in human adenocarcinoma A549 cells" [Eur. J. Pharmacol. 890 (2021) 173651].
Eur J Pharmacol. 2021 Oct 15;909:174453. doi: 10.1016/j.ejphar.2021.174453. Epub 2021 Aug 28.
8
Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1.
J Exp Clin Cancer Res. 2021 May 15;40(1):171. doi: 10.1186/s13046-021-01978-8.
9
Corrigendum to "Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells" [Eur. J. Pharmacol. 938 (2023) 175411].
Eur J Pharmacol. 2023 Dec 5;960:176183. doi: 10.1016/j.ejphar.2023.176183. Epub 2023 Nov 10.
10
Corrigendum to "A novel flavonoid isolated from the steam-bark of Ulmus wallichiana planchon stimulates osteoblast function and inhibits osteoclast and adipocyte differentiation" [Eur. J. Pharmacol. 658(2-3) 2011 65-73].
Eur J Pharmacol. 2018 Jul 15;831:103-105. doi: 10.1016/j.ejphar.2018.05.018. Epub 2018 May 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验